| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
9 companies
Opaleye Management Inc. serves as a 10% Owner at OCUL and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 230 buys and 102 sells. Those positions are worth an estimated $128.4M at current prices.
Historically, Opaleye Management Inc.'s trades have earned a middling insider score of 60/100 across 182 rated trades. Over a 12-month horizon, 45.4% of those trades were profitable, with an average 12-month return of +3.5%.
The biggest single holding is OCUL (~$45.2M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 4, 2021 | TARA Protara Therapeutics, Inc. | 10% Owner | Buy | 6,557 | $6.50 | $42,620.50 | +0.3% | -22.4% | -59.5% | |
| Nov 4, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 202,200 | $6.49 | $1,312,500.75 | -3.5% | -43.1% | -60.9% | |
| Oct 12, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 165,100 | $5.03 | $830,670.47 | -1.8% | -17.2% | -58.9% | |
| Aug 19, 2021 | HROW Harrow, Inc. | - | Buy | 52,500 | $8.45 | $443,362.50 | +1.6% | +29.4% | +1.8% | |
| Aug 18, 2021 | HROW Harrow, Inc. | 10% Owner | Buy | 72,500 | $8.62 | $624,697.15 | +1.1% | +24.3% | -2.4% | |
| Aug 6, 2021 | ETON Eton Pharmaceuticals, Inc. | 10% Owner | Sell | 604,500 | $5.83 | $3,523,187.20 | -5.6% | +9.4% | -49.9% | |
| Jul 21, 2021 | HROW Harrow, Inc. | - | Buy | 20,000 | $7.31 | $146,289.84 | +0.2% | +33.2% | -4.6% | |
| Jun 18, 2021 | HROW Harrow, Inc. | - | Buy | 74,584 | $8.34 | $622,389.01 | +1.2% | +10.3% | -21.4% | |
| Jun 15, 2021 | ETON Eton Pharmaceuticals, Inc. | - | Sell | 105,000 | $8.07 | $847,350.00 | -2.8% | -25.8% | -57.0% | |
| May 27, 2021 | ETON Eton Pharmaceuticals, Inc. | - | Sell | 242,300 | $8.52 | $2,064,511.00 | -2.0% | -40.5% | -62.7% |